Seite - 4 - in Advances in Neuroimmunology
Bild der Seite - 4 -
Text der Seite - 4 -
BrainSci. 2016,6, 19
Thedifferences insignal transductionpathwaysutilizedbyIL-6andchemokinescould indicate
differentbiologicalactions.However, signal transductionpathwaysdownstreamof theG-proteinand
tyrosinekinasestepcanmergeatcommonpathwaypartnersor targetsandleadtosimilarbiological
actions. Thus, it isnotsurprisingthatall threeneuroimmunefactorshaveneuronalorsynapticactions,
althoughtheactionsarenot identical.
Both neurons and glial cells express receptors and signal transduction pathways utilized by
IL-6R [41,43], CCR2 [44–46], andCXCR3 [47,48], and arepotential downstreamcellular targets of
the astrocyte producedneuroimmune factors. Because of the close association of astrocyteswith
neuronsandsynapses [39], actionsofcytokinesorchemokinesoneithercell typecouldpotentially
alterneuronalandsynaptic function.Downstreammolecular targetsofGPCRandIL-6Rpathwayscan
regulategeneexpression,whichmaybe instrumental indirectingneuroadaptivechangesassociated
withelevatedexpressionof IL-6,CCL2,andCXCL10 in theCNSof the transgenicmice.
4. IL-6,CCL2,orCXCL10TransgenicMice
All three linesof transgenicmicewith increasedastrocyteexpressionof IL-6,CCL2,orCXCL10
were generated by a similar approach, insertion of the transgene (mouse or human) for the
neuroimmunefactorunder transcriptional controlof theglialfibrillaryacidicprotein (GFAP)gene
promoter [29,34,49,50]. GFAP is an intermediatefilamentprotein expressedalmost exclusivelyby
astrocytes in theadultCNSandcommonlyusedasamarker forastrocytes [50,51]. More thanone
linewasgeneratedforeachneuroimmunefactor.Heterozygotes fromthefollowinglineswereused
for the studiesdiscussed in this review: IL-6 transgenic line 167 (IL-6 tg), CXCL10 transgenic line
CXCL10-10 (CXCL10tg),CCL2transgenic lineonaSJLbackground(CCL2-tgSJLmice),andCCL2
transgenic lineonaC57Bl/6Jbackground(CCL2-tg),whichweredevelopedfromtheCCL2-tgSJL
mice.Non-transgenic littermatesof therespective transgenic linewereusedascontrols. Ingeneral,
elevatedexpressionofotherneuroimmunefactorswasnotevident,orat lowlevel in these transgenic
lines [29,34,52], enabling investigationof theconsequencesof elevatedexpressionof the transgene
aloneor incombinationwithotherexperimentalmanipulations.
4.1. Expressionof IL-6,CCL2,orCXCL10 in theTransgenicMice
Because transgene expression in the transgenicmice is under control of theGFAPpromoter,
elevated expressionof IL-6, CCL2, orCXCL10 is linked toGFAPexpression. GFAPexpression in
astrocytesis initiatedduringthedevelopmentalperiod,whichoccursprimarilyduringthefirst3weeks
ofpostnatal life inmice.GFAPexpression in themousehippocampus isevidentat1daypostnatal,
increaseswithageuntil6dayspostnatal,andthenlevelsoffandremainsstablethroughadulthood[53].
Thus,neuronal/synapticexposure to theseneuroimmunefactors in the transgenicmiceoccursduring
an importantperiodofstructuralandsynapticdevelopmentandcouldaffectdevelopmentalpatterns.
Evidence is limitedonthis topic,but ingeneral,neuropathologyinthehippocampusof theIL-6,CCL2,
andCXCL10heterozygousmice isabsentorminimalupto3–6monthsofage,althoughhomozygous
micecanshowpathologyatearlyages [29,32,54,55]. Thus, if theelevatedexpressionof IL-6,CCL2,
orCXCL10alteredCNSdevelopment in the transgenicmice, theeffectsondevelopmentwerenot
pathologicalorwerecompensatedforbyotherchanges. In this review,discussionof the transgenic
micerefers to theheterozygotes.
CNSexpressionof IL-6,CCL2,orCXCL10hasbeenquantifiedin therespective transgenicmice
at themRNAand/orprotein levels. Studiesof IL-6-tgmice showed that IL-6mRNAwasevident
in theCNSat7dayspostnatal, increasedwithageandreachedapeakat3monthspostnatal (adult
stage), afterwhich a declinewas observed [52]. IL-6 transgene expressionwas demonstrated in
hippocampalastrocytesbyexpressionof the lacZreportergeneandimmunohistochemicaldetection
ofβ-gal [55].Constitutivesecretionof IL-6 fromastrocyteswasdemonstrated instudiesofastrocyte
culturespreparedfromCNSof the IL-6 tgmice [49]. IL-6 levelswere~150pg/mLinthesupernatant
fromastrocyteculturespreparedfromCNSof IL-6 tgmice, comparedwith<5pg/mLforsupernatant
4
zurück zum
Buch Advances in Neuroimmunology"
Advances in Neuroimmunology
- Titel
- Advances in Neuroimmunology
- Autor
- Donna Gruol
- Herausgeber
- MDPI
- Ort
- Basel
- Datum
- 2017
- Sprache
- englisch
- Lizenz
- CC BY-NC-ND 4.0
- ISBN
- 978-3-03842-571-7
- Abmessungen
- 17.0 x 24.0 cm
- Seiten
- 164
- Schlagwörter
- neuroimmune, cytokine, chemokine, glia cel, neuron, neurodevelopment, neuroimmune disorder, neurologic disease, psychiatric disease, neuronal injury
- Kategorie
- Medizin